Kestra Advisory Services’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,351
Closed -$5.23K 2250
2023
Q2
$5.23K Hold
10,351
﹤0.01% 2096
2023
Q1
$6.81K Buy
10,351
+154
+2% +$104 ﹤0.01% 2037
2022
Q4
$3.54K Sell
10,197
-146
-1% -$59 ﹤0.01% 2245
2022
Q3
$5K Sell
10,343
-3,000
-22% -$1.56K ﹤0.01% 2095
2022
Q2
$5K Buy
13,343
+1,804
+16% +$805 ﹤0.01% 2121
2022
Q1
$7K Buy
+11,539
New +$8.89K ﹤0.01% 1995
2021
Q4
Sell
-52,711
Closed -$98K 2217
2021
Q3
$98K Buy
52,711
+6,687
+15% +$15K ﹤0.01% 2058
2021
Q2
$146K Buy
+46,024
New +$115K ﹤0.01% 1922

Other funds holding ASXC

Kestra Advisory Services's ASXC Position: Q3 2023 in Review

Kestra Advisory Services sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 10,351 shares — an estimated $5.23K sold.

Kestra Advisory Services first reported a position in ASXC in Q2 2021 and held it in 8 quarters. The position peaked at $146K in Q2 2021. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

  • Kestra Advisory Services reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
  • Kestra Advisory Services sold 10,351 Asensus Surgical, Inc. shares in Q3 2023, an estimated $5.23K.
  • Kestra Advisory Services first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 8 quarters.
  • Kestra Advisory Services's Asensus Surgical, Inc. position peaked at $146K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Kestra Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.